Related Experiment Videos
Tumour markers--a diagnostic and therapeutic perspective
1Department of Nuclear Medicine, Singapore General Hospital.
Annals of the Academy of Medicine, Singapore
|March 1, 1990
Summary
Chemically diverse substances act as tumor markers, aiding cancer research and diagnosis. Radioisotope-labeled antibodies offer sensitive detection for clinical decision-making in cancer patient management.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Malignant cell transformation is linked to various chemical substances.
- These substances, while not entirely specific, serve as useful tumor markers.
- Their presence arises from altered cellular components and exposed molecular structures.
Purpose of the Study:
- To review chemically diverse tumor markers associated with malignant transformation.
- To explore the role of antibodies in cancer research, diagnosis, and therapy.
- To highlight the clinical utility of radioisotope-labeled antibodies in cancer management.
Main Methods:
- Selective review of literature on chemically diverse tumor markers.
- Discussion of the origins of tumor markers (e.g., altered epitopes, oncogene amplification).
- Examination of antibody-based approaches for cancer detection and treatment.
Main Results:
- Tumor markers are operationally useful despite lacking absolute specificity.
- Antibodies targeting tumor markers create new research, diagnostic, and therapeutic opportunities.
- Radioisotope-labeled antibodies demonstrate high sensitivity and specificity for clinical decision support.
Conclusions:
- Chemically diverse substances function as valuable tumor markers.
- Antibody-based strategies are revolutionizing cancer patient care.
- Advanced antibody labeling techniques enhance diagnostic accuracy and therapeutic efficacy.